https://www.youtube.com/watch?v=VtSgG6-96×0&feature=youtu.be
Start clip at 56:50. It will give you chills.
Thank you to Civilian Intelligence Network for digging up the film. In what can only be described as predictive programming, or a trial run, Theresa Tam “Canada’s top Doctor” takes part in a 2010 film about a fictional epidemic in Canada. Doesn’t get much more premeditated than shooting a film a decade in advance.
In the film (56:50 to 57:50) Tam talks approvingly (seeming almost giddy) about being able to enforce mandatory quarantines, using tracking bracelets, and only “worry later” about questions of an overreach. It’s difficult to make the clip look worse than it actually is. Seems that life is now imitating art.
And on a more petty note: there is something not quite human about those eyes.
1. Other Articles On CV “Planned-emic”
The rest of the series is here. Many lies, lobbying, conflicts of interest, and various globalist agendas operating behind the scenes, obscuring the “Great Reset“. The Gates Foundation finances: the WHO, the US CDC, GAVI, ID2020, John Hopkins University, Imperial College London, the Pirbright Institute, the BBC, and individual pharmaceutical companies. Also: there is little to no science behind what our officials are doing; they promote degenerate behaviour; the Australian Department of Health admits the PCR tests don’t work; the US CDC admits testing is heavily flawed; and The International Health Regulations are legally binding. See here, here, and here. The media is paid off, and our democracy is thoroughly compromised, as shown: here, here, here, and here.
Several articles in this series cover the lobbying by Bill Gates and other pharmaceutical companies in general. This is rampant at the Provincial and Federal levels, and goes on outside of Canada as well.
The reason for this focus is to give context. One can’t understand why politicians are pushing the vaccine agenda without realizing how much influence peddling goes on behind the scenes. Big pharma, to a large degree, is pulling the strings of our public officials. Hence the obsession with getting everyone vaccinated.
It must also be addressed that Bill Gates (among others), is promoting a depopulation agenda. While developing and pushing vaccines under the guise of promoting global health, Gates has spoken many times about how the world has too many people in it. Take that into consideration before getting the needle.
Beyond big pharma, there are many players using the opportunity as a chance to obtain power, or to wield more power. Many selfish actors are willing to perpetuate the lie for these reasons.
4. “Outbreak” On File With CDN Gov’t
This fictional film (or predictive programming) was done a decade ago and Public Safety Canada makes them available for the public to watch. Interesting side note: this was on 2010, and wasn’t Stephen Harper the Prime Minister at the time?
Outbreak [videorecording (DVD)] : anatomy of a plague / written & directed by Jefferson Lewis ; produced by Kenneth Hirsch
Location
Public Safety Canada Library
Resource
DVDs
Call Number
RA 644 .S6 O97 2010d
Authors
Lewis, Jefferson, 1951-
Hirsch, Kenneth.
National Film Board of Canada.
Mongrel Media.
Office national du film du Canada.
They even used the same picture for both profiles.
Dr. Tam has served as an international expert on a number of World Health Organization committees and has participated in multiple international missions related to SARS, pandemic influenza and polio eradication.
This may be stretching it, but Tam’s profile as Chief Public Health Officer of Canada is misleading. It refers to her roles in a past tense, suggesting she no longer has any involvement in the World Health Organization. But that is simply not true. AS for the assigned role by the Federal Government:
The Chief Public Health Officer (CPHO) is the federal government’s lead public health professional. The CPHO is responsible for:
Providing advice to the Minister of Health and President of the Public Health Agency of Canada on health issues;
Working with other governments, jurisdictions, agencies, organizations, and countries on health matters;
Providing an annual report to the Minister on the state of public health in Canada for tabling in Parliament; and
Speaking to Canadians, health professionals, stakeholders, and the public about issues affecting the population’s health.
The CPHO is also accountable for or has delegated responsibilities for public health-related provisions of the Public Health Agency of Canada Act, the Quarantine Act, the Human Pathogens and Toxins Act and the Department of Health Act.
In an Emergency
In a public health emergency, such as an outbreak or natural disaster, the Chief Public Health Officer is responsible for:
Briefing and advising Canada’s Minister of Health, the President of the Public Health Agency and others as appropriate;
Working with counterparts in other departments, jurisdictions, and countries, as well as with experts and elected officials, to communicate with Canadians about how to protect themselves and their families;
Personally delivering public health information to Canadians via media appearances, public statements, updates to the Public Health Agency web site, and columns and public advertisements in daily and community newspapers;
Providing direction to Public Health Agency staff, including medical professionals, scientists, and epidemiologists, as they plan and respond to the emergency;
Leading daily national teleconferences as appropriate with federal government scientists and experts to share information and plan outbreak responses; and
Coordinating with jurisdictions through regular teleconferences with Canada’s provincial and territorial Chief Medical Officers of Health and others.
This all is fine and good, except holding a position with the World Health Organization at the same time is not in the public interest. In times where WHO offers poor advice, Tam would have to choose between rejecting that advice, or adopting it and running interference.
Although the details are enough to be an article by themselves, Tam has shown repeatedly that this conflict-of-interest is to the detriment of Canadians.
6. GAVI Archives Available
A shout out to @SomeBitchIKnow (that’s her handle, not me being rude), for sharing this gold mine of information from GAVI, the Global Alliance for Vaccines and Immunizations.
When GAVI took down their site, they likely thought that the information they didn’t want saved would be lost. Not the case, as nothing is ever really erased.
7. The Coronavirus Rabbit-Hole
In a sense this is a prequel to the CV series coming out, though it’s a newer piece. Actually, Part 11 of the series (Ontario lobbying) is already up.
There isn’t just one person, one organization, or one fact to know. This planned-emic is a well coordinated and thought out attack on our livelihood. Know who is behind it, know who is being lobbied. There is so much that politicians and the media are not saying.
In fact, several pieces focus exclusively on the lobbying. If government officials are promoting mass vaccination, we should be asking why. Since they won’t answer truthfully, then check out who they have been talking to.
Bill 160 passed Third Reading in the Ontario Legislature at the end of 2017. However, since it never received Royal Proclamation, it’s not officially law. This will become important soon.
Like so many pieces of legislation, it was packed so full that it was impossible to properly sort out.
Ambulance Act
Anti-Racism Act, 2017
Broader Public Sector Accountability Act, 2010
Child and Family Services Act
Child, Youth and Family Services Act, 2017
City of Toronto Act, 2006
Commitment to the Future of Medicare Act, 2004
Coroners Act
Drug and Pharmacies Regulation Act
Electronic Cigarettes Act, 2015
Excellent Care for All Act, 2010
Freedom of Information and Protection of Privacy Act
Healing Arts Radiation Protection Act
Health Care Consent Act, 1996
Health Facilities Special Orders Act
Health Insurance Act
Health Protection and Promotion Act
Health sector payment transparency act, 2017
Independent Health Facilities Act
Local Food Act, 2013
Local Health System Integration Act, 2006
Long-Term Care Homes Act, 2007
Medical Radiation and Imaging Technology Act, 2017
Medical Radiation Technology Act, 1991
Ministry of Health and Long-Term Care Appeal and Review Boards Act, 1998
Municipal Act, 2001
Occupational Health and Safety Act
Ontarians with Disabilities Act, 2001
Ontario Drug Benefit Act
Ontario Energy Board Act, 1998
Ontario Mental Health Foundation Act
Oversight of Health Facilities and Devices Act, 2017
Patient Restraints Minimization Act, 2001
Pay Equity Act
Personal Health Information Protection Act, 2004
Private Hospitals Act
Public Hospitals Act
Public Sector Labour Relations Transition Act, 1997
Public Sector Salary Disclosure Act, 1996
Quality of Care Information Protection Act, 2004
Regulated Health Professions Act, 1991
Residential Tenancies Act, 2006
Retirement Homes Act, 2010
Smoke-Free Ontario Act
Social Contract Act, 1993
Substitute Decisions Act, 1992
Tobacco Damages and Health Care Costs Recovery Act, 2009
Purpose
.
1 The purpose of this Act is to require the reporting of information about financial relationships that exist within Ontario’s health care system, including within health care research and education, and to enable the collection, analysis and publication of that information in order to,
.
(a) strengthen transparency in order to sustain and enhance the trust that patients have in their health care providers and in the health care system;
.
(b) provide patients with access to information that may assist them in making informed decisions about their health care;
.
(c) provide the Minister and others with information for the purposes of health system research and evaluation, planning and policy analysis; and
.
(d) provide for the collection, use and disclosure of personal information for these purposes.
Interpretation, “payor”
.
3 Any of the following persons is a payor for the purposes of this Act if the person provides a transfer of value to a recipient:
.
1. A manufacturer that sells a medical product under the manufacturer’s own name or under a trade-mark, design, trade name or other name or mark that is owned or controlled by the manufacturer and that fabricates, produces, processes, assembles, packages or labels the product, even if those tasks are performed by someone else on the manufacturer’s behalf.
.
2. A person who fabricates, produces, processes, assembles, packages or labels a medical product on behalf of a manufacturer described in paragraph 1.
.
3. A wholesaler, distributor, importer or broker that promotes or facilitates the sale of a medical product.
.
4. A marketing firm or person who performs activities for the purposes of marketing or promoting a medical product.
.
5. A person who organizes continuing education events for members of a health profession on behalf of a manufacturer described in paragraph 1.
.
6. A prescribed person or entity.
.
Reporting obligations
.
4 (1) Subject to subsection (2), a payor shall report to the Minister the information set out in subsection (5) with respect to the following transactions:
.
1. A transfer of value provided directly by a payor to a recipient.
.
2. A transfer of value provided indirectly by a payor to a recipient through an intermediary.
Schedule 4 is the most interesting part.
SCHEDULE 4
health sector payment transparency act, 2017
The Schedule enacts the Health Sector Payment Transparency Act, 2017.
The purpose of the Act, as set out in section 1, is to require the reporting of information about financial relationships that exist within Ontario’s health care system, including within health care research and education, and to enable the collection, analysis and publication of that information in order to, among other things, strengthen transparency. The Act requires that certain transactions be reported to the Minister who shall analyse and publish the information. The Act establishes a framework for inspections and other compliance mechanisms. The Act provides for periodic review by the Minister.
Bill 160 Never Actually Proclaimed
According to CanLII, Bill 160 wasn’t proclaimed (brought into force), as of May 29, 2019, which was a full 6 months after it had cleared in the Legislative Assembly. The Ontario Government “does” make reference to the passing of Bill 160, but adds in the all-important disclaimer: ONCE PROCLAIMED INTO FORCE
A law that would have made Ontario the first province in which drug companies were forced to publicly disclose their payments to doctors is in limbo with less than two months to go before the data collection was supposed to begin.
Premier Doug Ford’s Progressive Conservative government has not enacted the regulations that would bring into force the Health Sector Payment Transparency Act, legislation that was hailed as a major step toward openness in medical marketing when the former Liberal government passed it nearly a year ago.
Health Minister Christine Elliott’s office would not say whether the Tories intend to proceed with the transparency law or abandon it.
In the meantime, the legislation has been left to languish alongside other laws the Liberals passed but did not execute before they were swept out of office in June.
“We know, in many cases, the health sector did not feel that the prior government engaged in proper consultation when enacting legislation,” Hayley Chazan, the minister’s press secretary, said in an e-mailed statement that declined to answer specific questions about the transparency law. “That’s why our government is broadly consulting with partners in health care and reviewing all legislation that has not yet come into force as part of our efforts to develop a long-term transformational health strategy.”
The law would have led to the release of massive amounts of new data about how the pharmaceutical industry tries to influence the practice of medicine in the province.
How convenient it is that a law passed in 2017 was never actually implemented. This would have forced drug manufacturers and consultants to disclose how much money they had been spending in order to push their drugs to the public at large.
Ford claims (as did Wynne) that a delay is necessary in order to consult various parties and look for ways to best implement it. So, then why go through the time and expense of drafting and debating legislation BEFORE the consultations were done and the details worked out? Why is doing it AFTER the fact a better alternative?
Or, could this just be a way of “appearing” to clamp down on lobbyist influence, while still ensuring that is goes ahead nonetheless? Doesn’t seem like a populist thing to do.
Of course, this is nowhere near all of them. Does it paint a clearer picture? The Ontario Government is on the receiving end of lobbying by the drug industry. But because Bill 160 wasn’t implemented, we won’t know if any money has changed hands.
Could this be the real reason Bill 160 was never implemented? All of these lobbying records look back enough on the surface. However, if money changed hands in order for certain drugs to be approved, or be sold in certain places, it ups the sleaziness considerably.
Kathleen Wynne passed Bill 160 in late 2017. She could have easily implemented it. So could have Doug Ford when he took power. Both had majority governments.
Keep in mind, this is not an exhaustive list of the drug lobbying that is going on in the Ontario Legislature. There is much more, and the above is just a sample of it.
Some of the lobbying at the Federal level has been published in earlier pieces on this site. However, this is not true at the Provincial level. The question that has to be asked is whether lobbying is playing a role in getting various Premiers to support the vaccination agenda.
The answer is yes, or at least it certainly looks like it. This article will focus on Alberta, now headed by Jason Kenney. Others will be addressed subsequently. Kenney is blatantly pro-vaxx, and people have to ask who is pulling the strings for this agenda.
Clearly, Wellington Advocacy and Counsel Public Affairs are not the only 2 groups lobbying the Alberta Government. But they are both very prominent.
Also noteworthy is that Kenney is a former Cabinet Minister in Stephen Harper’s Government. He is a twice-attendee of the Bilderberg meetings. Kenney has powerful connections.
Jason Kenney, like the Federal Government, and other Premiers, supports the agenda for mass vaccination. Unlike the Feds, though, Kenney hasn’t (so far) said that it will be mandatory, but we will have to see what becomes of it.
EDMONTON — Prime Minister Justin Trudeau defended his government Tuesday after Alberta’s premier suggested Ottawa is dragging its feet on approving potential screening devices and treatments for COVID-19.
On Sunday, Jason Kenney tweeted that he had directed staff to consider using tests, vaccines or medications “that have been approved by the high standards of at least one credible peer country’s drug agency.”
That of course is just a clip from a broader article. Point is, Kenney seems on board with vaccinations. He doesn’t want Ottawa potentially slowing it down.
2. Wellington Advocacy, ex-PMO Staffers
What we do
Wellington Advocacy helps you build, run and win campaigns.
.
After a decade of working alongside Stephen Harper on the campaign trail and in office, our team is uniquely positioned to help you build government relations strategies, digital campaigns, stakeholder coalitions and blueprints to run.
.
Government Relations
Our team will work with you to build and deliver a concise and compelling presentation to government. Drawing on vast public policy and government experience, we ensure the right people hear your message at the right time.
.
Digital
Finding and winning over an audience is central to any successful campaign. We know how to identify and engage audiences and will help you build a bespoke digital strategy to capture the attention you need to deliver your message.
This lobbying firm was with Stephen Harper for more than a decade, and even played a role in the PMO (Prime Minister’s Office). They brag about having influence. Now, they lobby (current) Alberta Premier Jason Kenney. Keep in mind, that Kenney was Immigration Minister for much of his time in Harper’s Government. All of this reeks of a conflict-of-interest.
According to the Lobbying Registry of Alberta, Wellington Advocacy has lobbied the Alberta Government 53 times since May 2019. While certainly not all of their clients are drug companies, several of as late, are.
DATE
LOBBYIST
CLIENT
SENIOR OFFICER
23-Apr-2020
Wellington Advocacy Inc.
Triple M Housing
Nick Koolsberge
23-Apr-2020
Wellington Advocacy Inc.
Spartan Bioscience Inc
Nick Koolsbergen
19-Apr-2020
Wellington Advocacy Inc.
AMD Medicom Inc
Nick Koolsbergen
22-Mar-2020
Wellington Advocacy Inc.
Bayshore Healthcare LTD
Nick Koolsbergen
22-Mar-2020
Wellington Advocacy Inc.
Shoppers Drug Mart
Nick Koolsbergen
3. Counsel Public Affairs, Inc.
Healthcare
Our team has extensive experience working across the health care sector, from hospital operations and broader health care industry governance, to service providers and product manufacturers, and to the regulated health professionals who support the system. Counsel has advocated on behalf of doctors, nurses, hospitals, pharmaceutical companies, pharmacies, medical device manufacturers, healthcare associations and patient groups on a wide range of mandates.
LOBBYING
Engaging decision makers with a powerful, persuasive and fact-based position is the key to success. With decades of experience working at all levels of government, we know how to effectively bridge the gap between those inside and outside of the political sphere to find solutions for your most important issues.
.
POLICY DEVELOPMENT
We know how government weighs options, evaluates impacts, and makes choices. We understand the policy process and how your organization can intervene effectively. We’ll help to ensure the facts are laid out, your case gets in front of the right people, and the policy implications are clear.
.
STAKEHOLDER AND INFLUENCER ENGAGEMENT
Skilled and targeted stakeholder management involves both recruiting allies and minimizing opposition. We can help you identify, track, and influence stakeholders.
Their LinkedIn page is filled with countless examples of Counsel Public Affairs attempting to control political narratives. Members have ties to many political parties, so they really are playing all sides.
11-Apr-2020
Counsel Public Affairs Inc.
Emergent BioSolutions Canada Inc. (formerly Adapt Pharma Canada Ltd.)
Philip Dew
Counsel does have offices in other provinces, and connections to many political parties.
4. Registered Lobbying Reports
24-Apr-2020
AstraZeneca Canada Inc.
Jane Chung
23-Apr-2020
Wellington Advocacy Inc.
Triple M Housing
Nick Koolsbergen
22-Apr-2020
Stosic & Associates Ltd.
Mint Pharmaceuticals Inc.
Aleksandar Stosic
16-Apr-2020
Hill + Knowlton Strategies
3M Canada Company
Sheila Wisniewski
15-Apr-2020
Global Public Affairs
Applied Pharmaceutical Innovation
Randy Pettipas
15-Apr-2020
Novartis Pharmaceuticals Canada Inc.
Christian Macher
11-Apr-2020
Counsel Public Affairs Inc.
Emergent BioSolutions Canada Inc. (formerly Adapt Pharma Canada Ltd.)
Philip Dewan
09-Apr-2020
Lundbeck Canada Inc.
Peter Anastasiou
09-Apr-2020
Rothmans, Benson, & Hedges
Peter Luongo
07-Apr-2020
Pfizer Canada ULC
Cole Pinnow
07-Apr-2020
Merck Canada Inc.
Anna Van Acker
06-Apr-2020
Alberta Pharmacists’ Association
Margaret Wing
01-Apr-2020
Janssen Inc.
Jorge Bartolome
This is of course not an exhaustive list of who has been lobbying the Government in Alberta. Nor is health the only topic that gets lobbied for.
But it is interesting to see how many interested parties are coming forward. And “interested” refers to those who will be able to make money off such a vaccine or other remedy. When there is a lot of money at stake, people must always be wondering who is possibly pulling the strings.
One thing seems clear though: the Alberta Government won’t be waiting around for Ottawa to make a decision. Whether AB ultimately decides to go the route of mass vaccinations is unknown. However, there are companies who would profit greatly from it.
It also can’t be understated the conflict of interest that arises when lobbyists — many of whom have ties to government officials — start lobbying those officials on matters that are not in the best interests of the people. Much like Crestview Strategy and many more, Wellington Alliance and Counsel Public Affairs rely on their personal connections to pass initiatives that their clients pay for.
Saini is listed many times in connection with the Lobbying Commissioner’s Office. Many of those communications reports are with pharmaceutical companies who are lobbying him.
Saini is a board member for the Canadian International Council. Here are the main founders that is lists. Some of these names should be familiar.
1. Raj Saini’s LPC Profile
A proud resident of Kitchener-Waterloo, Raj Saini has owned and operated an award-winning small business for nearly 20 years. His success as a small business owner comes from his focus on helping people achieve their health goals using evidence-based protocols to enable healing and encourage healthy lifestyles.
.
A committed and active supporter of local organizations, Raj works tirelessly to engage his community in politics and international affairs. He is a proud Rotarian of many years, a board member of the Canadian International Council, Waterloo Region branch and a long-time champion of Liberal values. He is passionate about improving the local economy, creating jobs and promoting the health and well-being of Kitchener Centre’s residents through intelligent, fiscally responsible environmental and health policy.
.
Raj earned his Bachelors of Science in Chemistry from the University of Toronto, and a Bachelors of Science in Pharmacy from Boston’s Northeastern University.
The above is taken directly from his profile. Let’s get into the issues that exist here, and why they are a problem.
2. Saini Co-Owned A Pharmacy
In 2017, Saini pandered in Parliament on the issue of World Pharmacist’s Day. No shocker, given his personal and professional stake in the industry.
KITCHENER — As a pharmacist, Raj Saini says he learned a few things about serving all segments of society. After getting elected to the House of Commons, he wants to keep doing that, but with a larger customer base — about 102,433 people, to be exact.
That’s the most recent census information available for Kitchener Centre, the riding that Liberal MP-elect Saini will represent after winning last Monday’s federal election in his first run at public office.
As the co-owner of the independent Greenbrook Pharmacy, it should come as no surprise that nothing tops Saini’s list of priorities as he heads to Ottawa more than the need for a national pharmacare policy.
Fewer and fewer Canadians have benefits that cover the costs of prescription drugs and those rising out-of-pocket medicine expenses are the missing link in the country’s universal health care coverage, he said.
Raj Saini is a pharmacist, and co-owns one as well. While there is nothing wrong with this (and is admirable) the strange connections shown later are a cause for concern.
In 2019, Saini rehashed the same old Liberal campaign promise for universal drug coverage. In all fairness though, the LPC has been campaigning on it since 1993 and has never delivered on it.
3. Saini Lobbied By GAVI In 2019
Jason Clark, who works for the firm Crestview Strategy, lobbied Saini on March 8, 2018, on behalf of GAVI. GAVI is the Gates-funded Global Alliance for Vaccines and Immunizations. This was after Saini had introduced M-132, and prior to the Committee hearings in Parliament.
4. Other Pharma Lobbying MP Saini
All of these records can be verified by searching Raj Saini’s name in the Office of the Lobbying Commissioner of Canada. This is by no means all of the records, but shows a pretty good indication of who he has been speaking with.
About
What makes the CIC unique is our network of 15 branches across seven provinces. This gives us a presence, in local communities, that is unparalleled in Canadian global affairs.
.
Thanks to this presence, Canadians from all walks of life, all ages, political opinions, and professions can discuss and learn about international affairs and contribute their views. In reflecting on the ideas and interests of a broad constituency of Canadians, the CIC demonstrates that our country’s foreign policy is not an esoteric concern of experts but benefits from direct citizen involvement.
.
As thousands of people join in an ongoing series of events and online discussions, the whole is greater than the sum of its parts. The result is a national conversation on our country’s role in the world.
.
We engage our members and the public to join the conversation through three types of activity: they can attend events, read our research and can share their opinions online.
Saini’s profile states that he is a Director at this organization (the Waterloo Branch). However, in searching him on the internal search, it doesn’t appear that he has contributed any publications to the organizations.
It’s interesting though: to be a Director at this group, which is looking for global solutions (on many issues). Saini introduced M-132, which will increase research and distribution of pharmaceuticals both in Canada and abroad. Certainly this is consistent with CIC’s agenda, but hard to tell if it is influencing the motion.
6. MP Saini Introduced M-132 In 2017
For a speech on passing M-132.
The text is below
Motion Text
That the Standing Committee on Health be instructed to undertake a study on ways of increasing benefits to the public resulting from federally funded health research, with the goals of lowering drugs costs and increasing access to medicines, both in Canada and globally; and that the Committee report its findings and recommendations to the House no later than one year from the time this motion is adopted.
HOW THE FEDERAL GOVERNMENT COULD FOSTER INNOVATION IN PHARMACEUTICAL RESEARCH AND DEVELOPMENT IN CANADA AND GLOBALLY
.
Witnesses suggested to the Committee that the federal government could address these challenges by increasing its investments in health research; promoting the creation of innovative alternative models of pharmaceutical R&D; and establishing strategic priorities for pharmaceutical R&D in line with both domestic and international population health needs.
(ii) Repurposing of Existing Drugs Dr. Keith Fowke, Professor, Department of Medical Microbiology and Infectious Diseases, University of Manitoba, told the Committee that federal funding of research focusing on examining ways to repurpose existing drugs that are safe, affordable and globally available to treat new conditions is another possible approach of reducing the costs of drug development, while ensuring affordable access to treatments. He explained to the Committee that his CIHR-funded research on HIV/AIDS examined the role that aspirin could play in preventing the spread of infection by reducing inflammation in cells in the genital tract that are susceptible to the HIV virus. His research showed that aspirin reduced the number of HIV target cells in the genital tract by 35%, which is paving the way for clinical trials in this area. Dr. Fowke recommended that CIHR continue to support innovative fundamental research that focuses on the repurposing of existing widely available generic drugs for the treatment of new conditions, an approach that reduces timelines and costs for R&D as these medications already exist
C. Develop a Strategic Framework for Federally Funded Health Research in Canada and Abroad
Finally, the Committee heard from both Drs. Nickerson and Yusuf that the federal government needs to develop a strategic framework that identifies priorities for health research funding that focuses on population health needs both in Canada and abroad. Though various federal government departments and agencies, including CIHR, the Public Health Agency of Canada and Global Affairs Canada have proposed priorities for federal health research funding both nationally and internationally, witnesses indicated that there is a need to review and better coordinate health research priorities across government to determine whether they are meeting population health needs. This priority setting would help identify areas where the federal government should target its investments in pharmaceutical R&D, which would leverage Canadian expertise across governments, universities, industry and civil society.
It cannot be overemphasized that these reports focus not only on cheap drugs for Canadians. They also are directed to the world at large. Presumably they will be sold at low rates, but since it’s not specified, they could be donated. Those are quotes from the November 2018 report that was released.
7. MP Saini Attended MIX Grand Opening
KITCHENER, ON, Jan. 10, 2020 (GLOBE NEWSWIRE) — Medical Innovation Xchange (MIX), Canada’s first industry-led hub for medtech startups, celebrated its official launch and ribbon-cutting ceremony on Friday, January 10, 2020 at its Kitchener headquarters. Mr. Simon Kennedy, Deputy Minister, Innovation, Science & Economic Development provided the keynote address on what infrastructure is required to help retain and successfully scale Canadian medtech startups. Honoured guests included Kitchener Mayor Berry Vrbanovic, Member of Parliament Raj Saini, Member of Parliament Tim Louis, and industry leaders including prominent medtech CEOs, investors, hospital administrators, and government officials.
MIX, spearheaded in June 2019 by Intellijoint Surgical CEO Armen Bakirtzian, joins the powerful community within the Toronto-Waterloo Innovation Corridor to offer Canadian medtech companies an environment to grow locally and go to market globally. MIX Residents have a unique opportunity to retain ownership in early stages and succeed by leveraging MIX resources to avoid early stage pitfalls and post-prototype growing pains. The successes of Intellijoint Surgical, which celebrated its landmark 10,000th surgery in April of last year, and other successful Canadian medtech strategic advisors, help illuminate the path to bootstrapping as an alternative to acquisition by, for example, global medical device and pharmaceutical companies or packing up and moving operations to the United States.
“We are experiencing a tech boom right across our region,” adds Tim Louis, MP for Kitchener Conestoga. “We excel at IP development, and have a global reputation in high-tech manufacturing – from automotive to aerospace. But we understand that more must be done to cultivate local successes. When IP leaves the country, we miss out on future opportunities, as well as the potential spillover effect from high-tech research. MIX will certainly help to address some of those gaps.”
Since the June 2019 announcement of its founding, MIX has already received dozens of inquiries from interested companies seeking to become part of the community. This will ensure Bakirtzian meets his commitment to fill the incubator’s office space with mature startups that would most benefit from peer-to-peer information exchanges over the course of their minimum 18-24 month occupancy. “We are committed to helping ‘grow our own’” says Bakirtzian, “and it starts with ensuring the most promising medtech startups have a home here at 809 Wellington Street where they can thrive and scale.”
MIX, the Medical Innovation Exchange, had it’s grand opening, on January 10, 2020. MP Saini was one of those in attendance. Since its launch, MIX has focused it’s services on the coronavirus epidemic, which happened very shortly afterwards. What a great, but coincidental timing this is. Here is another article covering the launch.
Bakirtzian and MIX’s inaugural Residents want to galvanize these realities for the medtech space and their many peers in the Kitchener-Waterloo area. Their vision also includes addressing tough questions about healthcare procurement policies, which impact the domestic healthcare market, and channels to access more mature sources of funding. They are keenly aware of the immediate and broader impact of their work.
“Canada is a place where innovation thrives – especially here in the Kitchener-Waterloo region.” says Raj Saini, MP for Kitchener Centre. “We offer one of the best economies in the world for new business ventures as well as small and medium enterprises. And medtech is an area rich in intellectual property — something Canadians lead at developing. But we need to improve at commercialization. Of patents filed in the past two years, 60% ended up with global companies within a year.”
“We are experiencing a tech boom right across our region,” adds Tim Louis, MP for Kitchener Conestoga. “We excel at IP development, and have a global reputation in high-tech manufacturing – from automotive to aerospace. But we understand that more must be done to cultivate local successes. When IP leaves the country, we miss out on future opportunities, as well as the potential spillover effect from high-tech research. MIX will certainly help to address some of those gaps.”
MIX, the Medical Innovation Xchange, doesn’t actually do any research itself. Instead, it is a hub, or a place of centralization for others to research. Although this is just starting out, it will be very interesting to see where things lead.
8. Waterloo Corporate Welfare
Today, Raj Saini, Member of Parliament for Kitchener Centre, on behalf of the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development and Minister responsible for FedDev Ontario, announced a contribution of $2.57 million for Nicoya to scale up operations and accelerate growth into new markets.
“This FedDev Ontario investment in Nicoya is wonderful news for Waterloo Region. Twenty-nine good-paying, highly-skilled jobs will be added in our community, and our thriving biotechnology and health sciences cluster will be strengthened. Our government is committed to ensuring the competitiveness of our region both at home and abroad.”
– Raj Saini, Member of Parliament for Kitchener Centre
Off topic, but Saini handed out $2.57 million to create 29 jobs, or more than $88,000/per job. Great use of taxpayer money.
9. Issue With Saini’s Connection
Raj Saini is a licensed pharmacist, but he has also been lobbied by drug companies (among others) for his entire time in office. One of those parties was GAVI, the Global Vaccine Alliance that is largely financed by Bill Gates and his Foundation. On the surface at least, these look like a clear conflict of interest.
Saini introduced M-132, to get the House of Commons Standing Committee on Health to study ways to increase pharmaceutical research. The people who appeared before the Committee and give submissions have vested interests in seeing this go ahead.
M-132 could be totally coincidental, but consider how it looks. The motion is introduced in 2017, the hearings are in the fall of 2018, and the recommendations are adopted in March 2019. Later that year, Event 201 would be held and the coronavirus “pandemic” would be unleashed.
How convenient it is that the Parliamentary hurdles were cleared in time for drug researching to be advanced.
The Canadian Government has adopted significant portions of the WHO’s vaccine agenda, including expanding it to include more and more items. Parliament has approved (see last article) increased funding for research and supply of more vaccines. The Government and Gates’ people seem to be in lockstep ideologically.
Even worse than the government simply going along with this is the propaganda elements. They refer to it as “overcoming vaccine hesitancy”. In practice, this amounts to little more than psychological manipulation in order to convince people that these vaccines are safe. Both the Canadian Government and the World Health Organization engage in this very shady tactic.
For some perspective on the vaccine agenda, let’s look at a partial timeline of events that are happening in Canada and elsewhere.
TIMELINE:
2000 – GAVI (Global Vaccine Alliance) formed
2003 – Nat’l Immunization Strategy Report released
2010 – At WEF, Gates announces $10B to develop vaccines
2014 – Research done into “vaccine hesitancy”
2015 – Journal of Vaccine article on “vaccine hesitancy”
2016 – $25M Committed in 2016 budget for more immunizations
2016 – ID2020 launched by Gates
2017 – M132 passed, to get more funding for big pharma
2018 – GAVI/Crestview lobbies Canadian politicians/bureaucrats
2018 – CANimmunize app launched for smartphones
2018 – HoC Committee on Health approves M-132
2018 – Measuring Behavioural, Social Drivers of vaxx meeting
2019 – Recommendations of M-132 formally adopted
2019 – Working Group (Gates/GAVI) to promote vaxx agenda
2020 – Canada’s economy is unnecessarily crashed
2020 – PM, Premiers talk about mandatory vaxx in Canada
The following sections will cover both initiatives that the Canadian Government has undertaken, as well as the public relations efforts to combat what they refer to as “vaccine hesitancy”.
4. CANimmunize Mobile App
In 2018, the CANImmunize App was released publicly. See this original YouTube video. If putting all your records on some app is becoming more mainstream, what’s to stop there from eventually being a biological record?
The CANimmunize app is promoted on the page. So the Government of Canada sees this as a totally valid and legitimate pathway to take. But don’t worry, as bad as that is, there are worse things to be considered.
There is of course ID2020, which Bill Gates is a major supporter of. He is in favour of creating a digital ID for everyone, and even goes as far as to propose embedding immunization records into people’s skin.
Preamble
Over the past several years, the Advisory Committee on Population Health and Health Security (ACPHHS) has supported development of a national approach to addressing immunization issues in Canada. During this period, numerous meetings and consultations with federal, provincial, and territorial (F/P/T) public health representatives and other relevant stakeholders were undertaken to identify and develop collaborative approaches to strengthening immunization in Canada.
The value of this collaborative work was reflected in the February 2003 First Ministers’ Accord on Health Care Renewal, which included direction to Health Ministers to continue their pursuit of a national immunization strategy. The 2003 Federal Budget provided $45 million over five years to assist in the continued pursuit of a national immunization strategy, as directed by First Ministers. Specifically, Health Canada is to receive $5 million in 2003-04 and $10 million in 2004-05 and ongoing. This funding will enable strengthened collaboration with the provinces, territories and key stakeholders to improve the effectiveness and efficiency of immunization programs in Canada, but will not be used for vaccine procurement
All of this seems harmless enough, but in 2003, a report had been released about the Government’s agenda of boosting vaccinations across Canada.
6. Nat’l Immunization Objectives: 2016-2021
Our next steps: NIS objectives 2016 – 2021
While immunization coverage in Canada today is good, we are not reaching any of the coverage goals set in 2005, leaving Canadians vulnerable to preventable illness. Furthermore, while rates of vaccine preventable diseases in Canada are low, recent measles and pertussis outbreaks demonstrate that Canadians are still at risk.
In its 2016 Budget, the Government of Canada committed $25M over five years to increase immunization coverage rates. While all NIS priorities are important, given the shared responsibility for immunization in Canada, and respectful of the collaborative, ongoing work of the NIS, F/P/T partners have worked together to establish a set of short term objectives that can capitalize on this new investment, leverage momentum and build from the 2013 priorities to provide F/P/T focus for the next five years.
This page outlines in extremely broad strokes the agenda for 2016 to 2021
7. CDA Immunization Partnership Fund
Today, not enough Canadians are vaccinated. As a result, Canadians are still at risk for needless illness and death from infectious diseases that could be prevented through vaccination. Recognizing this public health challenge, the Government of Canada committed $25 million in Budget 2016 to increase vaccination coverage in Canada.
The page does however go into considerable detail about “overcoming vaccine hesitancy”. This is short amounts to efforts to CONVINCE people that vaccines are safe.
increasing demand for vaccination
addressing gaps in
knowledge
attitudes
beliefs
And below we will get to some specific efforts being launched.
Creation of a Canadian Immunization Resource Centre (CANVAX)
This project, led by The Canadian Public Health Association, is designed to provide ready access to the latest evidence-based products and tools via the online Canadian Vaccination Evidence Resource and Exchange Centre. The Centre primarily targets those who are responsible for the planning, development and promotion of immunization programs, and aims to increase their understanding, awareness and capacity to enhance vaccine acceptance and uptake in Canada.
Decreasing Vaccine Hesitancy: Enhancing the knowledge and skills of health care professionals
This project, led by the Canadian Paediatric Society (CPS), has developed a workshop and an online education module on vaccine hesitancy. These courses will provide health care providers with a better understanding of the common causes of vaccine hesitancy and the most effective ways to counsel their patients and families to make informed decisions. Additionally, CPS has reinstated the online version of its Education Program for Immunization Competencies (EPIC), which is designed to help health care professionals provide accurate and complete information to their patients about immunization.
Examining and overcoming barriers to vaccine hesitancy in Yukon
Yukon Health and Social Services is implementing a project with the goal of understanding the factors that contribute to vaccine uptake and incomplete/non-vaccination. The data that is gathered will be used to inform evidence-based strategies aimed at improving vaccination service delivery and uptake in Yukon.
HPV Vaccination in Schools: Developing effective strategies for increasing vaccine coverage
The Institute national de santé publique du Québec, in collaboration with the ministère de la Santé et des Services sociaux du Québec, will develop and evaluate different strategies designed to increase vaccination coverage rates in select elementary schools within the province. These parent-focused strategies include motivational interviewing, education, decision making tools, and reminders to submit consent forms
Immunize Nunavut: Using data to inform practice
Immunize Nunavut, led by the Department of Health in Nunavut, will improve the quality of vaccination data that will then be used to inform tailored interventions aimed at increasing vaccination coverage rates and to strengthen existing vaccination delivery programs
(COMPLETED)
Enhancing adult immunization coverage in Prince Edward Island
This project, led by the Prince Edward Island Department of Health and Wellness, has implemented a multi-faceted, province-wide initiative to increase adult vaccination rates by working with health care providers to increase their ability to identify under and unvaccinated individuals through the development and use of an Immunization Assessment Tool. As well, this project will enhance health care provider’s ability to communicate more effectively with their patients about vaccination.
(COMPLETED)
Implementation of an educational strategy to promote immunization based on motivational interviewing techniques in maternity hospitals in Québec
In collaboration with provincial partners, the Centre Intégré Universitaire de Santé et Services de l’Estrie – Centre hospitalier universitaire de Sherbrooke implemented this project to increase infant vaccination coverage rates in Quebec. To do this, health care providers from the 13 largest maternity wards in Quebec received training in motivational interviewing techniques specific to infant vaccination. Motivational interviewing allows health care providers to better address the concerns of parents who are reluctant to vaccinate their children and to support them in their decision-making process regarding infant vaccination.
What is particularly disturbing here is that about half the programs seem focused on promoting and selling the vaccines. It comes across as propaganda the way they are worded.
However, it is about to get much, MUCH creepier than this. The World Health Organization has done extensive research on it. Parties including UNICEF, the US Centers for Disease Control (CDC), Gavi, the Vaccine Alliance, and the Bill and Melinda Gates Foundation all got together to discuss how to better pitch vaccines to the public.
8. Tricks To Beat “Vaccine Hesitancy”
The World Health Organization has done considerable research on the subject of “vaccine hesitancy”. This of course is the natural reaction of people to be reluctant to put needles of unknown substances into their bodies.
Improving vaccination demand and addressing hesitancy
Increasing and maintaining vaccination uptake is vital for vaccines to achieve their success. Addressing low vaccination requires an adequate understanding of the determinants of the problem, tailored evidence-based strategies to improve uptake, and monitoring and evaluation to determine the impact and sustainability of the interventions.
Hesitancy in relation to vaccination may affect motivation, causing people to reject it for themselves or their children. Hesitancy can be caused by individual, group, and contextual influences, as well as any vaccine-specific issues.
Given the potential for hesitancy to rapidly undermine vaccination coverage in specific settings, it is important that all countries take steps to understand both the extent and nature of hesitancy at a local level, on a continuing basis. Accordingly, each country should develop a strategy to increase acceptance and demand for vaccination, which should include ongoing community engagement and trust-building, active hesitancy prevention, regular national assessments of concerns, and crisis response planning
It’s fair to take from this, that the efforts to understand hesitancy do not at all seem rooted in any altruistic motivation. Rather, they seem designed to form the basis to manipulate and otherwise persuade people into taking something that could be extremely harmful to them.
Meeting participants, from left to right: Kerrie Wiley, Neetu Abad, Gilla Shapiro, Alina Lack, Wenfeng Gong, Nick Sevdalis, Julie Leask, Monica Jain, Gustavo Correa, Noel Brewer, Saad Omer, Cornelia Betsch, Charles Wiysonge, Gillian SteelFisher, Lisa Menning, Eve Dubé
In May 2019, a group of people got together to come up with ways to make mass vaccination an easier sell to the public. Read the report and decide whether this is harmless enough.
In addition to the above research, there are questionnaires that are available. Asking and probing for certain types of information will give the illusion that you are concerned with the person’s well being.
In January 2015, this paper was released, giving insight into the various reasons people are likely to avoid taking vaccines. It also provided helpful information to convincing the subject that it was still in their best interest.
There is of course more research available on the subject. But the point is that it has been extensively studied. A cynic might wonder if the WHO spends more effort researching ways to pitch vaccines to the public than they do researching to see if they are actually safe.
9. Vaccine Hesitancy Parallels Climate Scam
Although this may initially seem absurd, there is a parallel between overcoming “vaccine hesitancy” as the WHO and others call it, and selling the climate change scam to the public.
Consider the reviews done of Maxwell Boykoff here, here, and here. Boykoff, in his book Creative Climate Communications, outlined an extensive array of psychological and sociological tactics used to convince people that they were in danger from climate change.
In order words, the research was done into manipulation techniques. The same thing can be seen with vaccine hesitancy research.
10. Canada/WHO Vaccine Targets Of 2025
Now that the anxiety is out of your system, let’s look a bit into Canada’s objectives and targets for mass vaccinations.
As part of the National Immunization Strategy objectives for 2016-2021, vaccination coverage goals and vaccine preventable disease reduction targets were set based on international standards and best practices. The goals and targets are consistent with Canada’s commitment to World Health Organization (WHO) disease elimination targets and Global Vaccine Action Plan, while reflecting the Canadian context.
According to this, Canada’s goals are consistent with the commitments made to the Global Vaccine Alliance Plan, and to disease reduction targets.
Vaccination Coverage Goals by 2025
Vaccination coverage goals were developed for infants, childhood, adolescent and adult vaccines that are publically funded in all provinces and territories (PT). Progress toward the national vaccination coverage goals will be reported based on the data collected using national coverage surveys. Vaccine coverage monitoring at the national level takes into account variations in PT vaccination programs.
Infants and Children
To ensure children are protected through routine vaccination, a high vaccination coverage goal of 95% has been established for all childhood vaccines by two and seven years of age.
This level of vaccination coverage is based on the level of population protection required for measles, the most easily-spread vaccine preventable disease.
Don’t worry. Once you have been cured of your vaccine hesitancy, the Government has an extensive array of pharmaceuticals and medications that you will able to get for free. Don’t worry that many of these are being developed by people who think the world is overpopulated. Nothing to see here.
The catalyst for GVAP was the call by Bill and Melinda Gates at the 2010 World Economic Forum for the next decade to be the ‘Decade of Vaccines’.
Gavi, the Vaccine Alliance, established in 2000, was making newer vaccines accessible to the poorest countries, while the Global Immunization Vision and Strategy, launched in 2006, provided a common vision and specific strategies for protecting more people against more diseases. New vaccines were being developed that held even greater promise.
PREFACE
The Global Vaccine Action Plan 2011–2020 (GVAP) was developed to help realize the vision of the Decade of Vaccines, that all individuals and communities enjoy lives free from vaccine preventable diseases. As the decade draws to a close, it is time to take stock of the progress made under GVAP and to apply the lessons learned to the global immunization strategy for the next decade. This report has been prepared for the Strategic Advisory Group of Experts on Immunization (SAGE) by the SAGE Decade of Vaccines Working Group (Annex 1).
Development of GVAP The Decade of Vaccines Collaboration was launched in 2010 to develop a shared plan to realize this vision. The Collaboration was led by WHO, UNICEF, Gavi, the US National Institute of Allergy and Infectious Diseases, and the Bill & Melinda Gates Foundation, coordinated by the Instituto de Salud Global Barcelona, Spain, and funded by the Bill & Melinda Gates Foundation. A Leadership Council, comprising executives of the lead organizations and a representative of the African Leaders Malaria Alliance, provided sponsorship and strategic guidance.
HISTORY
Ministers of health unanimously endorsed GVAP at the 2012 World Health Assembly; the monitoring and evaluation framework was endorsed a year later. In the following years, Regional Vaccine Action Plans and national multi-year plans were developed or updated to align with GVAP. African stakeholders went further to build political will for immunization, convening the Ministerial Conference on Immunization in Africa in 2016. This meeting launched the Addis Declaration on Immunization, through which heads of state and ministers of health, finance, education and social affairs as well as local leaders made ten specific commitments to promote health on the African continent through continued investment in immunization.
The global monitoring, evaluation and accountability process was the only aspect of GVAP with dedicated resources. In this effort, GVAP indicators were added to the WHO/UNICEF Joint Reporting Form and SAGE established the Decade of Vaccines Working Group to assess progress and draft recommendations for course corrections. Through the decade, countries reported annually, WHO and partner agencies compiled progress reports, and the SAGE independent assessment report and its recommendations were reviewed annually as a standing agenda item at the World Health Assembly
12. World Economic Forum: 2010 Gates
In 2000, Gavi, the Vaccine Alliance was launched at the World Economic Forum Annual Meeting in Davos, with an initial pledge of $750 million from the Bill and Melinda Gates Foundation.
Gavi brings together key influencers from the public and private sectors to save children’s lives and protect the population’s health by increasing the equitable use of vaccines in lower-income countries. To date, the Vaccine Alliance has contributed to the immunization of 760 million children, saving more than 13 million lives.
The World Economic Forum has completely embraced the vaccination agenda, and heralds it as some salvation for humanity. it many times provided a platform for Gates and his vaccine push.
13. Would You Trust This Man?
(Bill Gates and depopulation, from 2011, clip from video)
https://www.youtube.com/watch?v=Gc16H3uHKOA
(Bill Gates and depopulation, from 2011, entire video)
https://www.youtube.com/watch?v=-WFa4bHC0Do
(Bill Gates, improved health care, overpopulation)
(Bill Gates: health and population correlation)
(Bill Gates: vaccines and Ebola virus)
Gates talks about improving the health and well being of mothers in the 3rd world by use of vaccines, and that it would lead to a lower population. However, it seems illogical that improving the health would lead to less children being born. Gates counters that parents will simply choose to have less children if they knew the ones they had would be healthier.
Gates has also spoken about the world being overpopulated, and claims it is causing environmental problems. One should be extremely concerned about taking vaccinations from someone who is interested in depopulation.
The research that the World Health Organization and its partners have done into “vaccine hesitancy” is downright creepy. If the vaccines produced are what they claim to be, it shouldn’t be a hard time pitching them for others to take.
The Canadian Government seems on board with the vaccination agenda. (See previous articles on this subject in Section #1). The Prime Minister and various Premiers openly call for mass vaccines. M-132 passed in Parliament, making it easier to fund future research. The University of Saskatchewan has long conducted research with partners that are Gates and UN funded. The Government has been lobbied at least 20 times on behalf of GAVI by Crestview Strategy, and the bureaucrats themselves seem to be okay with it.
CLICK HERE, for #0: Theresa Tam; archives; articles; lobbying. CLICK HERE, for #1: piece on Bill Gates, Pirbright, depopulation. CLICK HERE, for #2: Coronavirus research at U of Saskatchewan. CLICK HERE, for #3: Gates; WHO, ID2020; GAVI; Vaccines. CLICK HERE, for #4: Gates using proxies to push vaxx agenda. CLICK HERE, for #5: Crestview Strategy, GAVI’s lobbying firm. CLICK HERE, for #6: people GAVI/Crestview lobbied follow Gates.
Motion Text
That the Standing Committee on Health be instructed to undertake a study on ways of increasing benefits to the public resulting from federally funded health research, with the goals of lowering drugs costs and increasing access to medicines, both in Canada and globally; and that the Committee report its findings and recommendations to the House no later than one year from the time this motion is adopted.
In Canada and around the world, there is rising concern that innovative drugs produced by pharmaceutical companies are no longer affordable and are placing increasing strain on health care budgets. Policy makers have begun to examine ways that public funding for pharmaceutical research and development could address this issue. On 8 November 2017, the House of Commons adopted Private Members’ Business M-132, which requested that the House of Commons Standing Committee on Health (the Committee) “undertake a study on ways of increasing benefits to the public resulting from federally funded research, with the goals of lowering drug costs and increasing access to medicines, both in Canada and globally.”
On 16 and 18 October 2018, the Committee held two meetings as part of this study and heard from a range of witnesses including health researchers, health research funding organizations, patient groups and civil society organizations. Drawing on witness testimony and written submissions, this report examines the role the federal government can play in fostering pharmaceutical research and development both in Canada and globally to ensure that pharmaceutical drugs are accessible and affordable.
Note: Recommendations can be found starting at page 20 in the 2018 report released to the House of Commons.
HOUSE OF COMMONS STANDING COMMITTEE ON HEALTH CALLS ON THE GOVERNMENT OF CANADA TO FOSTER PHARMACEUTICAL RESEARCH AND DEVELOPMENT BOTH IN CANADA AND GLOBALLY THROUGH OPEN SCIENCE
Ottawa, November 26, 2018 –
Bill Casey, Chair of the House of Commons Standing Committee on Health, presented the Committee’s twentieth report today entitled, Towards Open Science: Promoting Innovation in Pharmaceutical Research and Development and Access to Affordable Medications both in Canada and Abroad.
The Committee’s study is in response to Member of Parliament Raj Saini’s Private Members’ Motion M-132, which requested that the Committee, “undertake a study on ways of increasing benefits to the public resulting from federally funded research, with the goals of lowering drug costs and increasing access to medicines, both in Canada and globally.”
In presenting the report to the House, Chair Bill Casey highlighted that “in our testimony, we heard loud and clear that more needs to be done to strengthen research and innovation in Canada. I thank Mr. Saini for bringing forth M-132, and for his efforts in ensuring that the Health Committee can hear why Canada must continue to be a leader in this field.”
Drawing on witness testimony heard over the course of two meetings held on 16 and 18 October 2018 and on 23 written submissions, the Committee’s report examines how increased federal investment in health research, across the continuum from fundamental to clinical research, would support the development of new medicines. However, witnesses also emphasized the importance of ensuring that federal funding in pharmaceutical research and development must also result in the creation of drugs that are affordable in Canada and abroad. Witnesses suggested that this could be achieved by fostering the creation of innovative models of pharmaceutical research that prioritize open science in both the development of new drugs and the repurposing of existing drugs. Witnesses explained that the Government of Canada could lead the way by developing a framework that sets priorities for pharmaceutical research and development and promotes open science through collaboration and leveraging of funding across governments, universities, health charities and private industry.
The Committee agrees with these findings and has included in its report nine recommendations that it believes will support the transformation of pharmaceutical research and development in Canada.
Recommendation 1
That the Government of Canada create a specific funding mechanism for the development of clinical trial research and infrastructure in Canada through the Canadian Institutes of Health Research.
. Recommendation 2
That the Government of Canada increase its funding for clinical trial research and infrastructure in Canada to 10% of the Canadian Institutes of Health Research’s budget to be on par with jurisdictions leading in this area, such as the United Kingdom and the United States.
. Recommendation 3
That the Government of Canada explore ways to incentivize clinical trial research in Canada for pharmaceutical drugs and incentivize and support the production of those drugs in Canada at an advantaged price for Canada and provide venture capital for the proponent.
. Recommendation 4
That the Canadian Institutes of Health Research attach a Global Access Licensing requirement to recipients of its research funding that wish to commercialize their research findings.
. Recommendation 5
That the Canadian Institutes of Health Research include in its existing research and development programs support for the development of open science models of drug discovery.
. Recommendation 6
That the Canadian Institutes of Health Research develop a framework for open science that supports collaboration and the leveraging of research funding among different partners in pharmaceutical research and development, including health charities, universities, governments, and private industry.
. Recommendation 7
That Health Canada develop regulatory incentives for pharmaceutical companies that commit to open access to their research data and affordable prices for their products.
. Recommendation 8
That the Government of Canada undertake a strategic review of its health-related research funding priorities across departments and agencies to enhance coordination, including Health Canada, Public Health Agency of Canada, Canadian Institutes of Health Research, Global Affairs Canada, and Innovation, Science and Economic Development Canada.
. Recommendation 9
That the Government of Canada explore the feasibility of the public manufacturing of generic medicines.
In the follow-up report, the recommendations were formally adopted.
As provided by the report, these are the names and ranks of the Committee.
STANDING COMMITTEE ON HEALTH
CHAIR
Bill Casey
VICE-CHAIRS
Marilyn Gladu (lobbied by GAVI)
Don Davies
MEMBERS
Ramez Ayoub
Doug Eyolfson
Raj Grewal
Ben Lobb
Ron McKinnon
John Oliver (Parliamentary Secretary — Non-Voting Member)
Sonia Sidhu
Len Webber
OTHER MEMBERS OF PARLIAMENT WHO PARTICIPATED
Randy Boissonnault
Terry Duguid
Randy Hoback
Tom Kmiec
Christine Moore
Raj Saini (lobbied by GAVI)
Dave Van Kesteren
CLERK OF THE COMMITTEE
Marie-Hélène Sauvé
Why is the list of the Committee Members here? Well, once you see who some of the connections are, it will likely make the report findings a lot more suspicious.
7. Committee Members & Pharma Lobbying
The above screenshots came from information provided in the Office of the Lobbying Commissioner of Canada. These are far from exhaustive, but show a snapshot at the lobbying that is going on in Canada. Members of this Parliamentary Committee are being lobbied by various drug companies. It’s not difficult to see that this is done in order to influence them.
8. Conflict Of Interest Here
The same committee members who are recommending that Canada undertake more research for pharmaceuticals are the same ones who are being lobbied by pharmaceutical companies. It’s not difficult to piece it together.
